Spread of GES-5 carbapenemase-producing Pseudomonas aeruginosa clinical isolates in Japan due to clonal expansion of ST235

Global emergence of the widespread Pseudomonas aeruginosa ST235 clone

(2018) P. Treepong et al.   CLINICAL MICROBIOLOGY AND INFECTION

Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa

(2018) Dinesh Subedi et al.   PLoS One

Emergence and Spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa

(2017) Tohru Miyoshi-Akiyama et al.   Genome Biology and Evolution

A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species

(2017) Kohei Uechi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli

(2017) Patricia J. Simner et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluation of the Carbapenem Inactivation Method for Detection of Carbapenemase-Producing Gram-Negative Bacteria in Comparison with the RAPIDEC CARBA NP

(2017) Elif Aktaş et al.   Microbial Drug Resistance

Successful control of an outbreak of GES-5 extended-spectrum β-lactamase-producing Pseudomonas aeruginosa in a long-term care facility in Japan

(2016) A. Kanayama et al.   JOURNAL OF HOSPITAL INFECTION

Molecular analysis of the integrons of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates collected by nationwide surveillance programs across Japan

(2015) Yoko Mano et al.   BMC MICROBIOLOGY

The increasing threat of Pseudomonas aeruginosa high-risk clones

(2015) Antonio Oliver et al.   DRUG RESISTANCE UPDATES

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania

(2015) G. Mikucionyte et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Evaluation of the Blue-Carba Test for Rapid Detection of Carbapenemases in Gram-Negative Bacilli: TABLE 1

(2015) Fernando Pasteran et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Characterization of novel VIM carbapenemase, VIM-38, and first detection of GES-5 carbapenem-hydrolyzing β-lactamases in Pseudomonas aeruginosa in Turkey

(2013) Meryem Iraz et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Blue-Carba, an Easy Biochemical Test for Detection of Diverse Carbapenemase Producers Directly from Bacterial Cultures

(2013) J. Pires et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Diverse Mobilized Class 1 Integrons Are Common in the Chromosomes of Pathogenic Pseudomonas aeruginosa Clinical Isolates

(2012) Elena Martinez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Complete Genome Sequence of Highly Multidrug-Resistant Pseudomonas aeruginosa NCGM2.S1, a Representative Strain of a Cluster Endemic to Japan

(2011) T. Miyoshi-Akiyama et al.   JOURNAL OF BACTERIOLOGY

Carbapenem-Hydrolyzing GES-Type Extended-Spectrum β-Lactamase inAcinetobacter baumannii

(2010) Rémy A. Bonnin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

GES Extended-Spectrum  -Lactamases in Acinetobacter baumannii Isolates in Belgium

(2010) P. Bogaerts et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0

(2010) Stéphane Guindon et al.   SYSTEMATIC BIOLOGY

Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum  -Lactamases GES-1 and GES-5 in Spain

(2009) E. Viedma et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diversity of  -Lactamases Produced by Ceftazidime-Resistant Pseudomonas aeruginosa Isolates Causing Bloodstream Infections in Brazil

(2009) R. C. Picao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Minor extended-spectrum β-lactamases

(2008) T. Naas et al.   CLINICAL MICROBIOLOGY AND INFECTION

Emergence of class 1 integron-associated GES-5 and GES-5-like extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa in South Africa

(2008) Christiaan De J. Labuschagne et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS